Earnings Summary

Curevac’s revenue jumped 47.01% since last year same period to $16.48Mn in the Q3 2023. On a quarterly growth basis, Curevac has generated 117.48% jump in its revenue since last 3-months.

Curevac’s net profit fell -2.34% since last year same period to $-48.68Mn in the Q3 2023. On a quarterly growth basis, Curevac has generated 27.79% jump in its net profits since last 3-months.

Curevac’s net profit margin jumped 30.39% since last year same period to -295.34% in the Q3 2023. On a quarterly growth basis, Curevac has generated 66.8% jump in its net profit margins since last 3-months.

Curevac’s earning per share (EPS) estimates for the current year stand at -0.21.

Curevac’s earning per share (EPS) jumped 12% since last year same period to -0.22 in the Q3 2023. This indicates that the Curevac has generated 12% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Curevac’s return on assets (ROA) stands at -0.18.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Curevac’s return on equity (ROE) stands at -0.49.